Lv5
962 积分 2023-04-13 加入
GLP-1-based therapies for diabetes, obesity and beyond
5小时前
待确认
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/phase 2 trial
1天前
已完结
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging
4天前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
5天前
已完结
Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
8天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease
8天前
已完结
Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances
8天前
已完结
In vivo engineering broadens CAR-T cell therapy use
14天前
已完结
In vivo engineering broadens CAR-T cell therapy use
14天前
已完结
Dual-payload ADCs move into first oncology clinical trials
21天前
已完结
皖公网安备34019202002308
